Alexandra D.J. Mancini's Insider Trades & SAST Disclosures
Alexandra D.J. Mancini's most recent trade in InMed Pharmaceuticals Inc was a trade of 240 Common Stock done at an average price of $0.2 . Disclosure was reported to the exchange on July 31, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Alexandra D.J. Mancini.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| InMed Pharmaceuticals Inc | Alexandra D.J. Mancini | Consultant | Sale of securities on an exchange or to another person at price $ 0.18 per share. | 31 Jul 2024 | 240 | 0 | - | 0.2 | 42 | Common Stock |
| InMed Pharmaceuticals Inc | Alexandra D.J. Mancini | Sr VP, Clinical Reg Affairs | 27 May 2024 | 485 | 52,000 | - | - | Employee Stock Option (Expiration) | ||
| InMed Pharmaceuticals Inc | Alexandra D.J. Mancini | Sr VP, Clinical Reg Affairs | 21 Jan 2024 | 121 | 52,485 | - | - | Employee Stock Option (Expiration) | ||
| InMed Pharmaceuticals Inc | Alexandra D.J. Mancini | Sr VP, Clinical Reg Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2023 | 45,000 | 52,606 | - | - | Employee Stock Option (Right to Buy) | |
| InMed Pharmaceuticals Inc | Alexandra D.J. Mancini | Sr VP, Clinical Reg Affairs | 16 May 2023 | 485 | 7,606 | - | - | Employee Stock Option (Expiration) | ||
| InMed Pharmaceuticals Inc | Alexandra D.J. Mancini | Sr VP, Clinical Reg Affairs | 08 Mar 2023 | 61 | 8,091 | - | - | Employee Stock Option (Expiration) | ||
| InMed Pharmaceuticals Inc | Alexandra D.J. Mancini | Sr VP, Clinical Reg Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2022 | 4,200 | 8,152 | - | - | Employee Stock Option (Right to Buy) | |
| InMed Pharmaceuticals Inc | Alexandra D.J. Mancini | Sr VP, Clinical Reg Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Nov 2022 | 4,200 | 8,152 | - | - | Employee Stock Option (Right to Buy) | |
| InMed Pharmaceuticals Inc | Alexandra D.J. Mancini | Sr VP, Clinical Reg Affairs | 02 Jun 2022 | 1,515 | 98,787 | - | - | Employee Stock Option (Expiration) | ||
| InMed Pharmaceuticals Inc | Alexandra D.J. Mancini | Sr VP, Clinical Reg Affairs | 20 Feb 2022 | 3,030 | 100,302 | - | - | Employee Stock Option (Expiration) | ||
| InMed Pharmaceuticals Inc | Alexandra D.J. Mancini | Sr VP, Clinical Reg Affairs | 24 Jan 2022 | 12,121 | 103,332 | - | - | Employee Stock Option (Expiration) | ||
| InMed Pharmaceuticals Inc | Alexandra D.J. Mancini | Sr VP, Clinical Reg Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Oct 2021 | 35,000 | 115,453 | - | - | Employee Stock Option (Right to Buy) | |
| InMed Pharmaceuticals Inc | Alexandra D.J. Mancini | Sr VP, Clinical Reg Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2020 | 35,000 | 35,000 | - | - | Employee Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges